[1]
“LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS”, FMHR, vol. 4, no. 3, pp. 3196–3217, Mar. 2026, Accessed: Aug. 06, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3537